In what is perhaps the first use of the term “palliadelic,” Dr Lou Lukas at the University of Nebraska’s Medical Centre is planning to explore the effects of psilocybin in patients in palliative care.
Many clinical trials with psychedelics have taken place with patients in palliative care. In these trials, psychedelics have been shown to alleviate many of the psychological distress that is associated with patients in this setting.
Based on these results and more, it may soon be the case that “pallidelic care” becomes a viable treatment option for people in palliative care.